Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/23793Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Ryland, Georgina L | - |
| dc.contributor.author | Barraclough, Allison | - |
| dc.contributor.author | Fong, Chun Yew | - |
| dc.contributor.author | Fleming, Shaun | - |
| dc.contributor.author | Bajel, Ashish | - |
| dc.contributor.author | Hofmann, Oliver | - |
| dc.contributor.author | Westerman, David | - |
| dc.contributor.author | Grimmond, Sean | - |
| dc.contributor.author | Blombery, Piers | - |
| dc.date | 2020-07-09 | - |
| dc.date.accessioned | 2020-07-13T06:49:11Z | - |
| dc.date.available | 2020-07-13T06:49:11Z | - |
| dc.date.issued | 2020-10 | - |
| dc.identifier.citation | British Journal of Haematology 2020; 191(1): 123-126 | en |
| dc.identifier.uri | https://ahro.austin.org.au/austinjspui/handle/1/23793 | - |
| dc.language.iso | eng | - |
| dc.title | Inotuzumab ozogamicin resistance associated with a novel CD22 truncating mutation in a case of B-acute lymphoblastic leukaemia. | en |
| dc.type | Journal Article | en |
| dc.identifier.journaltitle | British journal of haematology | en |
| dc.identifier.affiliation | Department of Clinical Haematology, Alfred Hospital, Melbourne, VIC, Australia | en |
| dc.identifier.affiliation | Department of Clinical Haematology, Austin Health, Heidelberg, Victoria, Australia | en |
| dc.identifier.affiliation | Department of Pathology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia | en |
| dc.identifier.affiliation | Centre for Cancer Research, University of Melbourne, Melbourne, VIC, Australia | en |
| dc.identifier.affiliation | Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia | en |
| dc.identifier.affiliation | Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, VIC, Australia | en |
| dc.identifier.affiliation | Olivia Newton-John Cancer Research Institute, Heidelberg, Victoria, Australia | en |
| dc.identifier.doi | 10.1111/bjh.16949 | en |
| dc.type.content | Text | en |
| dc.identifier.orcid | 0000-0002-4990-0961 | en |
| dc.identifier.orcid | 0000-0002-9902-0022 | en |
| dc.identifier.orcid | 0000-0001-5773-103X | en |
| dc.identifier.pubmedid | 32648276 | - |
| dc.type.austin | Letter | - |
| local.name.researcher | Barraclough, Allison | |
| item.grantfulltext | none | - |
| item.openairetype | Journal Article | - |
| item.languageiso639-1 | en | - |
| item.fulltext | No Fulltext | - |
| item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
| item.cerifentitytype | Publications | - |
| crisitem.author.dept | Olivia Newton-John Cancer Research Institute | - |
| crisitem.author.dept | Clinical Haematology | - |
| Appears in Collections: | Journal articles | |
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.